Mattarollo, Stephen R
Chemotherapy and zoledronate sensitize solid tumour cells to Vgamma9Vdelta2 T cell cytotoxicity. [electronic resource]
- Cancer immunology, immunotherapy : CII Aug 2007
- 1285-97 p. digital
Publication Type: Journal Article
ISSN: 0340-7004
Standard No.: 10.1007/s00262-007-0279-2 doi
Subjects--Topical Terms: Adenocarcinoma--immunology Antineoplastic Agents--pharmacology Apoptosis--drug effects Breast Neoplasms--immunology Burkitt Lymphoma--immunology Carcinoma--immunology Cell Line, Tumor--drug effects Cisplatin--pharmacology Colorectal Neoplasms--immunology Concanavalin A--pharmacology Cytotoxicity, Immunologic--drug effects Diphosphonates--pharmacology Doxorubicin--pharmacology Drug Screening Assays, Antitumor Drug Synergism Etoposide--pharmacology Female Genes, T-Cell Receptor delta Genes, T-Cell Receptor gamma Humans Imidazoles--pharmacology Interferon-gamma--biosynthesis Lovastatin--analogs & derivatives Lung Neoplasms--immunology Male Membrane Glycoproteins--analysis Neoplasms--immunology Perforin Pore Forming Cytotoxic Proteins--analysis Prostatic Neoplasms--immunology Receptors, Antigen, T-Cell, gamma-delta--immunology T-Lymphocyte Subsets--immunology Urinary Bladder Neoplasms--immunology Vincristine--pharmacology Zoledronic Acid